Sept 11 (Reuters) - Intercept Pharmaceuticals said on Thursday it is withdrawing its liver disease drug from the U.S. market following a request from the Food and Drug Administration. This comes as ...

Ocaliva, a farnesoid X receptor agonist, was withdrawn from the U.S. market due to FDA concerns about liver injury in patients. Initially approved in 2016 under an accelerated pathway, Ocaliva faced ...

Explore emerging attack methods, evolving AI-driven threats, supply chain risks, and strategies to strengthen defenses and ...

Your weekly strategic brief on the cyber threat landscape. Uncover the deeper patterns behind attacks, from bootkit malware ...

Britain is poised to deploy fighter jets and an air defence system to Poland after Nato shot down Russian drones over allied territory for the first time in its history. The Telegraph understands John ...

We won't know for a while whether or not Kawhi Leonard had a "no-show"endorsement deal that would trigger discipline about salary cap circumvention. The NBA has hired a law firm to investigate the ...